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Abstract
Background: Healthcare systems face the problem of insufficient resources to meet the needs of ageing populations and
increasing demands for access to new treatments. It is unclear whether doctors and consumers agree on the main
challenges to health system sustainability.
Methodology: We conducted a mail survey of Australian doctors (specialists and general practitioners) and a computer
assisted telephone interview (CATI) of consumers to determine their views on contributors to increasing health care costs,
rationing of services and involvement in health resource allocation decisions. Differences in responses are reported as odds
ratios (OR) and 99% confidence intervals (CI).
Results: Of 2948 doctors, 1139 (38.6%) responded; 533 of 826 consumers responded (64.5% response). Doctors were more
concerned than consumers with the effects of an ageing population (OR 3.0; 99% CI 1.7, 5.4), and costs of new drugs and
technologies (OR 5.1; CI 3.3, 8.0), but less likely to consider pharmaceutical promotional activities as a cost driver (OR 0.29, CI
0.22, 0.39). Doctors were more likely than consumers to view ‘community demand’ for new technologies as a major cost
driver, (OR 1.6; 1.2, 2.2), but less likely to attribute increased costs to patients failing to take responsibility for their own
health (OR 0.35; 0.24, 0.49). Like doctors, the majority of consumers saw a need for public consultation in decisions about
funding for new treatments.
Conclusions: Australian doctors and consumers hold different views on the sustainability of the healthcare system, and a
number of key issues relating to costs, cost drivers, roles and responsibilities. Doctors recognise their dual responsibility to
patients and society, see an important role for physicians in influencing resource allocation, and acknowledge their lack of
skills in assessing treatments of marginal value. Consumers recognise cost pressures on the health system, but express
willingness to be involved in health care decision making.
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Introduction
Healthcare systems in both developed and emerging economies
face the problem of insufficient resources to meet the anticipated
health care needs of all citizens. Ageing populations, longer life
expectancy, increasing demand for services, new technologies and
new medicines all contribute to the financial pressures. Doctors
and patients (consumers) are aware of these pressures [1]. To those
working in health services these pressures lead to implicit or
explicit rationing [2]; patients experience these effects as waiting
lists for services and limited access to some medicines or
procedures in the public health system [3].
The moral dimensions of healthcare rationing have been widely
debated [2,4,5]. Some argue that a doctor’s sole responsibility is to
his or her own patients (patient advocacy role) [6–8], giving
primacy to the patient’s needs over possible social concerns about
inequity. Others see the physician’s responsibility as encompassing
the efficient use of medical resources (public interest advocacy) as
well as the interests of the individual patient [5,9]. This sense of
sharing responsibility for the management of scarce resources by
physicians, other experts and consumers has been posited as
‘‘protecting the medical commons’’ [10,11]. While there are calls
for the medical profession to engage more in improving systems of
care and population health, neither medical education nor the
practice environment has fostered this [3,12,13].
Pressures in the Australian health care system mirror those in
other settings. Concerns about unsustainable rises in health care
costs have been flagged in a series of intergenerational health
reports [14]. All Australians have access to publicly subsidised
treatment in a public hospital, which is free at the point of care for
everyone. Medicare also subsidises community-based treatment by
general practitioners and specialists [15]. Where practitioners
‘bulk bill’ Medicare for their fees the patient does not pay an
additional co-payment. Patients cannot access specialists directly –
they must be referred by a GP, so these professional groups have a
co-dependent rather than competitive relationship. In 2007–8, 53
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private health insurance [16]. This is a voluntary option (with tax
incentives), and supplements the services available through
Medicare. The type of insurance varies, and covers some costs
in private hospitals and services such as private dental, optical, and
ambulance services. Access to pharmaceuticals is via the taxpayer
funded Pharmaceutical Benefits Scheme (PBS) [17]. Patients pay a
fixed amount or co-payment for each prescription, the amount
depending on their welfare status. A ‘safety net’ cuts in with
heavily discounted prescriptions after a certain number have been
dispensed in a calendar year.
Australian doctors work with this complex mix of publicly and
privately funded services. It is unclear to what extent Australian
physicians recognise these issues and see a role for themselves in
improving the efficient management of the health care system. We
also know little about the Australian general public’s opinions
about health care spending [18]. In a climate of concern about
rising health care costs, the media are drawing attention to the
apparently insatiable demand for services, challenging whether
patient expectations are realistic, and whether current models of
service delivery are sustainable [19–21].
In view of the paucity of data on the views of doctors about their
roles in a financially constrained system, we aimed to compare
doctors’ and consumers’ perceptions of the Australian health care
system and measure their concerns about rising health care costs.
We wished to explore their views on factors that contribute to
increasing health care costs and where the responsibilities lie for
managing these costs. Specifically, we wished to probe their views
about the need to restrict access to health care services (‘rationing’)
and who should be involved in such decisions. Finally, given their
different roles in the health care system, we wanted to examine
whether the views of GPs and specialists differed on these issues.
Methods
Ethics statement
The surveys and the project were approved by the University of
Newcastle Human Research Ethics Committee and the Hunter
Area Research Ethics Committee. In the case of the participating
doctors (mail survey), return of the completed questionnaire was
accepted as informed consent. Consumer participants in the study
were randomly selected from the Electronic White Pages
(telephone directory) and were sent pre-notification letters
describing the study. Consumers gave verbal consent to participate
at the time of the telephone interview; this consent was recorded
by the Hunter Valley Research Foundation (HVRF) who
administered the questionnaires on behalf of the researchers.
Verbal consent is a standard procedure used by the HVRF based
on extensive experience conducting telephone surveys of this type;
requiring written consent produces low response rates and survey
samples unlikely to be representative of the study population.
Methods of recruitment and for obtaining consent were approved
by the two Ethics Committees.
Survey development
The underlying concepts of costs and responsibility for
managing costs were derived from the literature [5–9,18,22–24].
Items for the doctor mail survey and the Computer Assisted
Telephone Interviews (CATI) of consumers were developed from
instruments used in other studies exploring respondents’ views on
health care cost issues [18,25,26]. We included questions about
factors we believed to be relevant in the Australian setting. In
addition, we conducted two focus groups with local medical
practitioners (one with five general practitioners, the second with
eight specialists). Transcripts of the focus group were coded for
themes; these themes were used to guide the development of
survey items.
Survey questions
As far as possible we used the same items and response scales for
the doctor and consumer surveys (24 items common to both),
making minor modifications to the wording of a small number of
terms in the consumer survey only to account for different levels of
knowledge of medical terminology and concepts. Direct compar-
isons between doctors and the public were confined to those items.
Questions common to the surveys of doctors and
consumers. Attitudes towards the health care system in
Australia: 1 item assessing the quality of health care services (5-
point scale Very poor to very adequate) and 1 item assessing concern
about the costs of health care (4-point scale Concerned to Not at all
concerned). Possible causes of increasing health care costs: 14 items
(4-point Likert scale No contribution to Major contribution). Attitudes
towards managing health care costs, the responsibilities of doctors,
allocating health care resources: 7 items scored using a 5-point
Likert scale Strongly disagree to Strongly agree.
Respondents in both surveys were asked to indicate whether they
would bewilling tobeinvolvedindeciding how healthdollarsshould
be spent. If they were not willing, they were asked to nominate who
they would prefer to make these decisions on their behalf.
Consumer only questions. Awareness of health care costs
(Decreasing, Increasing, Staying the same), and actions being taken to the
control these costs (Too little, About the right amount, Too much).
We recorded the gender and age (18–44 years, 45–59 years,
$60 years) of respondents, private health insurance and
concession card status. The latter two categories are not mutually
exclusive: some low income families choose to purchase additional
private insurance to avoid public hospital waiting lists and to
access private hospital services (27). We examined responses for
the consumers by age, gender, private insurance and concession
card status.
Doctor only questions. For the doctor only questions, we
compared responses for GPs and specialists. One question sought
views on the ease of access to health care services (5-point Likert
scale Very poor to very adequate); 5 questions addressed the
contribution of new technological advances and practice issues
to increasing health care costs (4-point Likert scale No contribution to
Major contribution); 12 items sought agreement with statements
about health care costs and their influence on medical practice;
and 6 items focussed on rationing and cost containment (5-point
Likert scale Strongly disagree to Strongly agree). We recorded the
gender, practice location, medical specialty and years since
graduation for these doctors and compared these demographic
characteristics for mail survey respondents and non-respondents
and with the overall commercial database from which the sample
was chosen.
A two-phase pilot of the doctor mail survey was conducted; the
first with 24 GPs and specialists; the revised survey, which included
minor wording changes, was administered to a further five GPs
and specialists. A three-phase pilot of 30 interviews was conducted
for the consumer CATI. Minor modifications were made to the
interview script to clarify the meaning of several questions for
consumers and these were tested in subsequent phases of the pilot.
Copies of the doctor and consumer surveys are available on
request.
Participants and Recruitment
Doctor survey. A list, comprising a random sample of 1500
General Practitioners (GPs) and 1500 specialists was obtained
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(AMPCo Direct, http://www.ampcodirect.com.au). The specia-
lists were chosen from 13 specialties in proportion to their gender,
specialty and State representation in the database. The
anonymous survey was distributed by mail in May 2006, with a
follow-up survey sent to all participants three weeks later.
Consumer survey. The Hunter Valley Research Foundation
administered the survey using a Computer Assisted Telephone
Interview (CATI) system. Households in New South Wales (NSW),
Australia were randomly selected from the Electronic White
Pages. Pre-notification letters were sent to the selected households
describing the aims and methods of the study. A minimum of 6 call
attempts were made to contact each household, and once contact
had been made, at least another 5 attempts were made to speak to
the respondent to obtain either a completed interview or a refusal.
Respondents were aged 18 years or over and randomly selected
based on age relative to other householders (e.g. youngest, second
oldest). The survey took approximately 20 minutes; interviews
were completed between April and June 2006.
Analysis
Descriptive statistics (proportions) were used to summarise the
data. Responses for each item are reported separately. Likert scale
responses were dichotomised into major or moderate contributor to
costs (vs no contribution or little contribution) and agree and strongly
agree (vs strongly disagree, disagree or neither agree nor disagree) in
order to compare responses between doctors (specialists plus GPs
combined) and consumers, and between specialists and GPs for
questions only asked of the doctors. Differences between groups
are reported as odds ratios (OR), with the consumers as reference
group for the doctor versus consumer comparisons and GPs as the
reference group for the specialist versus GP comparisons. Because
we performed multiple comparisons we were conservative in our
calculations and report here the Odds Ratios with their 99%
confidence intervals.
Results
Response rates
Doctor survey. 1139 responses were received from 2948
eligible contacts; the 52 ineligible contacts included envelopes
returned to sender, retired/deceased doctors, person unavailable
for duration of survey, giving a survey response rate of 38.6%.
After exclusion of incomplete survey forms, 1118 doctors (514
GPs, 604 specialists) were included in this analysis. There were no
statistically significant differences in the distributions of specialty,
state and gender between survey respondents, the mail-out sample,
or in the overall database of practising doctors from which the
sample was drawn (data not displayed). This suggested our survey
respondents were generally representative of GPs and specialists in
Australia.
Consumer survey. A total of 533 interviews were completed
from 826 eligible contacts giving a response rate of 64.5%. Among
respondents, 37.5% were male; ages ranged from 18 to 89 years
(mean 52 years); 58% had private health insurance and 44.8%
reported holding a health care concession card. Rates of private
health insurance were comparable to those reported for the overall
Australian population in the year of the study [27].
General views on health care services in Australia
Doctors were much more likely than consumers to rate the
quality of health care services provided to Australians as adequate or
very adequate (81.2% doctors, 40.2% consumers; OR 6.4, 99% CI
4.7, 8.8). Specialists were more likely than GPs to rate access to
these services as adequate or very adequate (64.9% vs 56.8%; OR 1.4,
99% CI 1.0, 2.0).
Most consumers (91%) recognised health care costs were
increasing, with 76% responding that too little was being done
to control them.
The costs of providing health care services were an issue for
both doctors and consumers; doctors were less likely than
consumers to choose the highest level of concern on the response
scales (26.2% vs 85.7%; OR 0.17, 99% CI 0.13, 0.23), however
doctors were more likely than consumers to respond they were
fairly concerned about costs (52.4% vs 26.2%; OR 5.0, 99% CI 3.6,
7.0). Consumer concerns about costs were age-related, with those
aged $60 years more likely to respond concerned than those aged
,60 years (78.2% vs 62.4%; OR 2.2, 99% CI 1.2, 3.9).
Views on causes of increasing health care costs (see
Table 1)
Population characteristics. Doctors were generally more
likely to identify an ageing population and more people with
chronic illness as a cause of increasing health care costs than
consumers, although the difference was only statistically significant
for the question about the role of ageing populations (96.5% vs
90.2%; OR 3.0, 99% CI 1.7, 5.4).
Newadvancesandpracticeissues. Doctorswere significantly
more concerned than consumers about the costs of new medicines
and interventions, and availability of high-tech equipment and
procedures than consumers (OR 5.1, 99% CI 3.3, 8.0 and OR 2.1,
99% CI 1.4, 3.0 respectively). While there was a trend for doctors to
be more concerned than consumers about the costs associated with
the practice of defensive medicine for fear of litigation, this difference
was not statistically significantly different (OR 1.3, 99% CI 0.90, 1.8).
Two-thirds of both doctors and consumers were concerned about the
c o s t so fn e wt r e a t me n t sf o rc a n c e ra sam a j o ro rm o d e r a t ec o n t r ib u t o r
to increasing health care costs.
Social context. Doctors were significantly more likely than
consumers to see community expectations of access to the latest
technologies as a major or moderate contributor to increasing
health care costs (76.7% vs 67%; OR 1.6, 99% CI 1.2, 2.2).
However, doctors were less likely than consumers to attribute
increasing health care costs to people not taking responsibility for
keeping themselves healthy (67.2% vs 85.6%; OR 0.35, 99%CI
0.24, 0.49), patients expecting a test or prescription at every visit
(49.6% vs 64.4%; OR 0.55, 99%CI 0.41, 0.73), and to lower levels
of social support (informal care) in the community (53.9% vs
64.9%; OR 0.63, 99% CI 0.47, 0.84). Sixty-one percent of
consumers were concerned about the cost implications of patients
wasting medicines by hoarding or filling repeat prescriptions but
not using the medicine; this last question was not asked of doctors.
External pressures. Doctors were much less likely than
consumers to report that they considered the following to be
important cost drivers: external pressures from drug company
promotion to doctors (36.7% vs 66.4%; OR 0.29, 99% CI 0.22,
0.39), drug company advertising to consumers (37.6% vs 65.9%;
OR 0.31, 99% CI 0.23, 0.42), and the activities of lobby groups
and public pressure to fund particular diseases (48.8% vs 60%; OR
0.64, 99% CI 0.48, 0.84).
Attitudes towards managing health care costs (see
Table 2)
Doctors and consumers differed significantly in their attitudes
towards managing health care costs. More doctors than consumers
agreed that patients should be required to pay a greater share of
their health care costs to increase their cost-consciousness (48.1%
vs 31.7%; OR 2.0, 99% CI 1.5, 2.7). Both doctors and consumers
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care; although the great majority of doctors and consumers saw a
role for Government in this process, this view was less common
among doctors (85.7% vs 92.9%; OR 0.45, 99% CI 0.27, 0.75).
Fewer doctors than consumers saw a role for the medical
professions in educating the public (47.8% vs 74.1%; OR 0.32,
99% CI 0.23, 0.43). Doctors were significantly less likely than
consumers to consider that only the treating doctor and patient
should decide whether a treatment is worth the cost (30% vs
67.5%; OR 0.20, 99% CI 0.15, 0.27), or that a treatment should
be offered regardless of how high the cost, and how small the
benefit, of treatment might be (28.3% vs 82.9%; OR 0.08, 99% CI
0.06, 0.11).
Similar proportions (70%) of doctors and consumers identified a
role for public consultation about rationing decisions and
allocation of health care resources.
While one-third of consumers agreed that it is not the doctors’
responsibility to be concerned about health care costs to society,
89.8% of consumer respondents agreed that doctors have an
obligation not to waste the money that taxpayers have provided
for health care. A minority (35.5%) of consumers considered that
the cost of a medical treatment should be considered only when
the patient must pay all or part of the cost. Around one half of
consumers (51.4%) agreed that the Government has a duty to
provide the money necessary to meet all the health needs of the
population.
Specialists compared to GPs
Views on causes of increasing health care costs. Specialist
doctors and general practitioners held broadly similar views on
issues relating to waste, duplication and inefficiency that might
influence costs in the health care system (see Table 3). However,
specialists were significantly less likely than GPs to see waste in the
public hospital system as a cost driver (44% vs 57.6%; OR 0.58,
99% CI 0.42, 0.80).
Managing health care costs, rationing and cost con-
tainment. There were few differences between specialist doctors
and GPs on issues concerning management of costs in the health
care system (see Table 4). However, more specialists than GPs
considered that physicians need more training in recognising and
identifying marginally beneficial services and that the present
remuneration system provides no incentive to be cost conscious
(OR 1.4, 99%CI1.0, 2.0andOR 1.6, 99% CI1.2, 2.2respectively).
Additionally, specialists were less likely than GPs to report
prescribing or ordering tests because they felt the need to be seen
to be doing something for the patient (15.2% vs 21.8%; OR 0.64,
99% CI 0.43, 0.97).
Around two thirds of specialists and GPs recognised a role for
their profession in helping to control health care costs and only
30% of both groups held that their sole responsibility was the care
of the patient before them. However, for around 44% of the
doctor respondents, concern about the societal costs of health was
reported not to influence the management of individual patients.
For the majority of doctors (60% specialists, 54% GPs) cost-
effectiveness information alone was not sufficient to make them
change their practices. Yet, 88% of each group agreed that it is
reasonable to consider costs when the test, drug or intervention
was likely to be of marginal value. Around one-third of
respondents agreed that a PBS listing for a medicine meant that
it had been assessed as cost-effective (a ‘‘value-for-money’’ choice).
Table 1. Moderate or major contributors to increasing health care costs - Doctors (specialists and GPs combined) versus
consumers.
n (%) stating a major or moderate contributor to heath care costs
Doctors
N=1118
Consumers
N=533
Odds ratio
(99% CI)*
Population characteristics
Ageing population 1079 (96.5) 481 (90.2) 2.99 (1.67, 5.42)
More people with chronic illnesses 987 (88.3) 454 (85.2) 1.31 (0.87, 1.96)
New advances and practice issues
Development of expensive new medicines and interventions 1055 (94.4) 408 (76.5) 5.13 (3.32, 8.01)
Availability of high-tech medical equipment and procedures 978 (87.5) 411 (77.1) 2.07 (1.44, 2.98)
Practice of defensive medicine for fear of litigation 900 (80.5) 408 (76.5) 1.26 (0.90, 1.76)
New treatments for cancer 734 (65.7) 350 (65.7) 0.99 (0.75, 1.34)
Social context
Community expectations for access to the latest technologies 857 (76.7) 357 (67.0) 1.62 (1.19, 2.20)
People not taking responsibility to keep themselves healthy 751 (67.2) 456 (85.6) 0.35 (0.24, 0.49)
Decreases in informal care (e.g. by family and friends) 603 (53.9) 346 (64.9) 0.63 (0.47, 0.84)
Doctors’ reluctance to refuse patient requests for tests, drugs 590 (52.8) 281 (52.7) 1.00 (0.76, 1.32)
Patients expecting a test or prescription at every doctor’s visit 555 (49.6) 343 (64.4) 0.55 (0.41, 0.73)
External pressures
Lobby group and public pressure to fund particular diseases 546 (48.8) 320 (60.0) 0.64 (0.48, 0.84)
Drug company advertising to persuade people to ask for
medicines (in newspapers, television current affairs)
420 (37.6) 351 (65.9) 0.31 (0.23, 0.42)
Drug company promotions to doctors to prescribe medicines 410 (36.7) 354 (66.4) 0.29 (0.22, 0.39)
*Consumers are the reference category.
doi:10.1371/journal.pone.0019222.t001
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GPs in their expressed attitudes towards rationing and cost
containment. Most notably, both groups of doctors were strongly
of the view that physicians have a role in health administration
with the intent of influencing the allocation of health care
resources (92.5% specialists, 89.7% GPs).
Health care resource allocation
Consumers were more likely than doctors to indicate a personal
willingness to have a role in deciding how health dollars should be
spent (57% consumers, 43.2% specialists, 29.6% GPs p,0.0001).
Consumers who were unwilling to be personally involved
nominated doctors (39.7%) or other health professionals (17.9%),
politicians or government representatives (30.6%), or consumer
groups (16.6%) as having a role in making rationing decisions on
their behalf. Of 717 doctors who reported being unwilling to be
involved in resource allocation decisions, 91.5% nominated other
doctors as first or second preference with 66% ranking health
economists as first or second preference. Consumers and
politicians were ranked first or second preference for only 16.2%
and 7.7% respectively.
Discussion
Both doctors and consumers believe that the health care
system is under pressure because of rising costs; but there were
striking differences between the two groups on what was
contributing to these problems and how, and by whom, they
should be managed.
Overall, doctors appeared less concerned than consumers about
the threat posed by increasing costs to the sustainability of the
healthcare system. However, they were more concerned than
consumers with the effects of an ageing population, the
consequential high prevalence of chronic diseases, and the related
costs of new drugs and new technologies. They were also more
likely than consumers to view ‘community demand’ for new
technologies as a major cost driver. Doctors were more likely than
consumers to consider that patients should be expected to pay a
greater share of healthcare costs.
In contrast, consumers were more likely than doctors to
attribute rising costs to people not maintaining their own health,
expecting a prescription at every visit, and there being less social
support generally in the community than previously. Consumers
were more likely than doctors to identify the adverse effects of
Table 2. Attitudes towards health care costs and rationing - Doctors (specialists and GPs combined) versus consumers.
n (%) agreeing or strongly agreeing with statement
Doctors
N=1118
Consumers
N=533
Odds ratio
(99% CI)*
Attitudes towards health care costs
Patients should pay a greater part of the health care bill so they will be
more cost-conscious
538 (48.1) 169 (31.7) 2.00 (1.50, 2.68)
The Government should educate the public about the true costs of health care 958 (85.7) 495 (92.9) 0.46 (0.27, 0.75)
Doctors should educate their patients about the true costs of health care 534 (47.8) 395 (74.1) 0.32 (0.23, 0.43)
Only the treating physician and the patient should decide if a
treatment is ‘‘worth the cost’’
333 (29.8) 360 (67.5) 0.20 (0.15, 0.27)
Not matter how small the chance of benefit, the physician should offer
a medical treatment regardless of the cost
316 (28.3) 442 (82.9) 0.08 (0.06, 0.11)
It is not the doctor’s responsibility to be concerned about the costs of
health care to society
156 (14.0) 185 (34.7) 0.31 (0.22, 0.42)
Rationing and health care resource allocation
The public should be consulted about rationing decisions and allocation of
health care resources
784 (70.1) 375 (70.4) 0.99 (0.73, 1.34)
*Consumers are the reference category.
doi:10.1371/journal.pone.0019222.t002
Table 3. Moderate or major contributors to increasing health care costs - Specialists versus GPs.
n (%) stating a major or moderate contributor to heath care costs
Specialists
N=604
GPs
N=514
Odds ratio
(99% CI)*
New advances and practice issues
Increases in standard diagnostic tests (routine tests, investigations) 474 (78.5) 431 (83.9) 0.70 (0.46, 1.06)
Interventions that offer minimal benefits for their cost 397 (65.7) 304 (59.1) 1.32 (0.96, 1.84)
Duplication of tests, investigations (GPs/specialists/hospitals) 292 (48.3) 255 (49.6) 0.95 (0.69, 1.30)
Wasting of resources in the public hospital system 266 (44.0) 296 (57.6) 0.58 (0.42, 0.80)
Uncapped budgets (fee-for-service for GPs, private practice) 228 (37.7) 164 (31.9) 1.29 (0.93, 1.81)
*GPs are the reference category.
doi:10.1371/journal.pone.0019222.t003
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were more likely to consider that decisions about expensive
treatments should be left to doctors and their patients, and also to
consider that treatment should be offered irrespective of its cost.
Like doctors, the majority saw a need for public consultation when
decisions were made about new treatments, but they were more
likely to report a willingness to be involved in such decisions. Both
doctors and consumers identified the need for better education of
the public about health care costs, although differed in who should
provide this education.
This study did not assess doctors’ awareness of the cost
implications of their own decisions. Most doctors recognised
increases in the use of standard diagnostic tests as a contributor to
costs, however it is unclear whether this was viewed as over-
utilisation (of tests, procedures and specialist visits) that has been
described in other settings [28]. Not only are there cost
implications of more tests and early treatment intervention, tests
may lead to incidental findings and unnecessary anxiety, and
subsequent diagnostic labels can lead to treatments where the
benefits of early intervention are unclear [29].
Attitudes of respondents
It seems that consumers tend to judge other consumers more
harshly than do doctors. While consumers may see themselves as
responsible medicine and health service users [30], they appear to
be less certain about the behaviours of others, seeing irresponsible
and wasteful practices as contributors to increasing health care
costs. US consumers have likewise recognised their contribution to
wasteful healthcare spending associated with obesity, smoking and
poor adherence to drug regimens, compounded by behaviours
such as going to emergency rooms for non-emergency care, and
demands for costly treatments and technologies [31].
Doctors were more inclined to identify the ageing in the
community and increasing prevalence of chronic diseases, and the
availability of new treatments, as major cost drivers. But they were
not free of subjective judgments. They identified patient
expectations of access to new services as a substantial contributor
to increasing costs. This is not a new suggestion, and perceptions
influence actions. Doctors’ opinions about patient expectations for
a medicine have been shown to be a strong determinant of
prescribing [32]. While this survey cannot address the question of
Table 4. Attitudes towards health care costs and rationing - Specialists versus GPs.
n (%)agreeingorstronglyagreeingwith statement
Specialists
N=604
GPs
N=514
Odds ratio
(99% CI)*
Attitudes towards health care costs and influence on medical practice
As individual clinicians, physicians should play a role in helping to control
health care costs
407 (67.4) 327 (63.6) 1.18 (0.85, 1.65)
My concerns about the social cost of health care do not change my behaviour
when treating individual patients
260 (43.0) 233 (45.3) 0.91 (0.66, 1.25)
My only responsibility is the care of my patient, regardless of the cost 185 (30.6) 152 (29.6) 1.05 (0.74, 1.49)
When deciding how to treat a patient, I think about other uses of the health
care money (opportunity cost)
155 (25.7) 148 (28.8) 0.85 (0.60, 1.22)
It is reasonable to consider cost when the test, drug or intervention is likely to
be only of marginal benefit
539 (89.2) 452 (87.9) 1.14 (0.69, 1.88)
Physicians need more training in recognizing and identifying marginally
beneficial services
363 (60.1) 264 (51.4) 1.43 (1.04, 1.96)
Undergraduate and intern training programs should include sessions on
cost-effective medical practices and prescribing
457 (75.7) 363 (70.6) 1.29 (0.90, 1.85)
Cost-effectiveness information alone is probably not enough to persuade me
to change my practice patterns
361 (59.8) 279 (54.3) 1.25 (0.91, 1.72)
I sometimes prescribe or order tests because I feel the need to be seen to
be doing something for the patient
92 (15.2) 112 (21.8) 0.64 (0.43, 0.97)
I am indifferent to drug costs 52 (8.6) 37 (7.2) 1.21 (0.67, 2.24)
A PBS listing means the Government has assessed the drug as being
cost-effective (‘value-for-money’).
190 (31.5) 172 (33.5) 0.91 (0.65, 1.28)
Under present remuneration system there is no incentive to be cost conscious 351 (58.1) 237 (46.1) 1.62 (1.18, 2.23)
Rationing and cost containment
There is a legitimate need for cost containment in today’s health care environment 522 (86.4) 432 (84.0) 1.21 (0.77, 1.90)
Rationing decisions are an inevitable part of medicine 457 (75.7) 378 (73.5) 1.12 (0.78, 1.61)
Costs to society should always be considered when making clinical decisions 233 (38.6) 208 (40.5) 0.92 (0.67, 1.28)
Medical people have a role in administration to influence the allocation of
health care resources
559 (92.5) 461 (89.7) 1.43 (0.81, 2.53)
I would be willing to implement rationing decisions made by groups informed
by doctors
344 (57.0) 263 (51.2) 1.26 (0.92, 1.74)
I would be willing to implement rationing decisions made by government authorities 182 (30.1) 132 (25.7) 1.25 (0.88, 1.78)
*GPs are the reference category.
doi:10.1371/journal.pone.0019222.t004
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are well-founded, there is evidence that doctors tend to
overestimate patient expectations [33]. When patients are fully
informed about treatment options and given help with decision-
making, demand for some types of interventions, including surgery
has been shown to decrease [34]. However, patients with complex
and serious illnesses generally wish to delegate authority for
decision-making about treatments and procedures to their doctor
[32,35].
Consumers expressed stronger views than doctors about the
impact of the pharmaceutical industry on professional practices.
The available evidence shows that some types of industry contact
have adverse effects on prescribing [36]. In an interesting parallel
to consumers’ views of themselves and others, doctors tend to
acknowledge the influence of industry on their peers but not
themselves.
While the views of consumers and doctors are probably
subjective, a number of the concerns they expressed mirror those
identified by Government as drivers of increasing health care costs.
The 2010 Intergenerational Report [14] used projections on past
spending patterns to foreshadow future cost pressures from the
interaction of an ageing population and increasing demand for
health services and the funding of new technologies. These were
reflected in growth of costs of hospitals, medical services and
pharmaceuticals due to an ageing population, and an increased
prevalence of chronic diseases. The Report also identified growth
in spending on residential aged care as a driver of future health
care costs, noting this will be influenced by the mix between
residential care and care in the community.
The reality of rationing
Most doctors in this survey recognised rationing as an inevitable
feature of medical practice. This is consistent with evidence from
surveys conducted in a variety of settings [37]. While this may be
accepted as inevitable by health care workers, consumers tend to
see rationing in terms of failure of politicians to increase funding to
meet health care needs [1]. In this study, just over half of the
consumers suggested Government should provide the money
needed to meet all of the health care needs of the population.
Responses to increasing costs
While acknowledging the need for restraint, respondents to this
study were unclear about how rationing should be applied.
Doctors were more inclined to give weight to decisions informed
by the opinions of other doctors than those made only by
government authorities. However, they acknowledged the impor-
tance of engaging the public in rationing decisions. Others have
suggested that this ‘‘administrative gatekeeping’’ [38] may be the
most ethical response to rationing for doctors, allowing them to
implement fair cost-reducing guidelines passed at higher levels
within the health care system, while at the same time avoiding
having to make rationing decisions in individual cases. As in an
earlier Australian study [18], the consumers in this study expressed
willingness to participate in such resource allocation decisions.
But within the doctor-patient relationship saying no is hard, and
complicated by the interdependence, respect, concern and
affection in this relationship [39]. This may pose the greatest
challenge to GPs who have ongoing relationships with patients and
their families and is reflected in responses in this survey – more
GPs than specialists in this survey felt that no matter how small the
chance of benefit and regardless of the cost, the physician should
offer all treatment options to patients. However, a consequence of
this position of trust is that the GP is well positioned to improve the
quality of decisions for patients [34].
Consumers responding to this survey felt that doctors should tell
patients about medical treatments regardless of costs and how
small the likely benefits. However, knowing about treatments they
cannot afford or service shortages that directly affect them may
distress patients [40–42]. The dilemma for doctors is that failing to
tell patients about all treatment options might be viewed as
patronising and as a betrayal of trust, and not acting in the
patient’s best interest [43]. If rationing is used it should be overt
rather than covert with cost considerations explicit, transparent
and consistent [13].
Responses at a societal level
Although respondents to our surveys recognised the importance
of public involvement in decisions about health resource
allocation, there is no agreement in the literature about the best
approaches for doing this [44,45]. Italian developments include
the use of citizen juries to deliberate on health care decisions like
prostate cancer screening [46,47]. Public participation in discus-
sions of policy options requires knowledge and understanding of
the complexity of the health care system [48]. Some have argued a
role for the public in advising on the allocation of health care
resources but not for rationing decisions [4].
Mostly, discussions about rationing tend to focus on how to
assess the value of new technologies [49]; less often discussed is the
notion of ‘disinvestment’ in health care technologies [13], and the
reduced use or elimination of potentially wasteful practices [50].
However, this requires knowledge of, or an ability to identify,
treatments of marginal value; doctors in this study identified a
need for greater skills in this area. In the face of increasing
pressures on health care financing, educating physicians to be cost
aware is important. Some argue it is a critical responsibility of
medical schools and residency programs to provide this training;
the challenge being how to get ‘low’ real-world concerns such as
costs into medical school curricula dominated by ‘high knowledge’
including molecular biology and genomics [13,51]. Doctors in this
survey reported the need for more training in assessing marginal
services but even provided with information on cost-effectiveness
many said they were unlikely to change their practices. Sessions
and Detsky [52] have recently proposed a framework for such
medical education to equip doctors for their dual roles as patient
advocates and allocators of resources – a core course examining
economic influences on clinical decisions and practical application
of the principles in clinical and residency curricula.
Making rational choices relies on good information on
comparative effectiveness and cost-effectiveness. Medical journal
articles and reviews should be an important source of information.
A recent review [53] highlights some difficulties. Fewer than one-
third (31.7%) of studies evaluating medications published in six
high impact general and internal medicine journals (June 2008
and September 2009) were comparative studies and few focused
on safety and cost issues. Many cost-effectiveness studies are flawed
and industry funding appears to be an important source of bias
[54]. This underscores the importance of impartial sources of
information such as the guidance provided by health technology
assessment bodies like the National Institute for Health and
Clinical Excellence (NICE) in the UK and the Canadian Agency
for Drugs and Technologies in Health (CADTH).
In an environment of concern about increasing health care costs
there are opportunities for governments, health policy makers and
medical educators to inform the debate about health spending.
Government has a role in making costs and the limits of health
care funding more visible to both doctors and consumers. Given
the expressed willingness of some doctors and consumers to have a
role in resource allocation decisions, policy makers need to find
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decision-making. Informed citizen juries currently being evaluated
in a number of countries may provide a useful model for consumer
engagement. As some doctors have indicated a need for further
training about economics, medical educators should consider the
development of undergraduate and postgraduate programs to
meet this need. These alone will not manage the problems of finite
resources and increasing demand, however they will contribute to
a more informed and inclusive debate about future health funding.
Study limitations
The study has a number of limitations. We asked consumers to
focus on health care policy not their personal experiences of health
care and we avoided reference to specific clinical conditions or
treatments. Responses may have differed for chronic conditions
amenable to medical management compared to life-threatening
diseases. A criticism might be that consumers don’t know how the
health care system works so can’t comment on sources of
increasing health care costs. However, their concerns about the
costs of new technologies mirrored those of doctors.
A potential criticism of this study is the different response rates
in the surveys of doctors and consumers. The higher response rate
from consumers was achieved by random digit dialling. While
males were under-represented among the consumer respondents,
this is a common feature of telephone surveys of this type [55]. As
Australia has a parallel public private funding system for health it
could be argued that insurance status could have influenced
responses. However, rates of private health insurance in our
respondents were comparable to those in the Australian
population [27] and we found no differences in responses based
on this factor. It was not feasible to conduct a survey of doctors
using random digit dialling and we only had postal addresses for
the doctors selected in the sample. While the response rate from
the doctors’ survey was low, it is comparable to response rates to
mail surveys by medical practitioners [56] and other mail surveys
of GPs and specialists conducted by us [57,58]. Importantly, there
were no statistically significant differences in the distribution by
specialty, state and gender between survey respondents and non-
respondents, and all doctors in the commercial AMPCo database
from which the sample was drawn, the responses should be
generally representative of GPs and specialists in Australia.
A major strength of this study is that doctor and consumer
surveys were conducted over a comparable period of time.
Although the survey methods that we used differed for the doctors
and consumers, the techniques were appropriate and likely to
maximise the response rates in each case. There was sufficient
common material to enable us to perform valid comparisons of the
two responding groups.
Conclusion
In Australia, doctors and consumers appear to hold different
views on the sustainability of the healthcare system, and a number
of key issues relating to costs, cost drivers, roles and responsibilities.
Doctors recognise their dual responsibility to patients and to
society, see an important role for physicians in health care
administration to be able to influence resource allocation, and
acknowledge a lack of training in assessing treatments of marginal
value. Consumers recognise cost pressures on the health system
and express willingness to be involved in health care decision
making.
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